OncoCyte (LTS:0KCC) COGS-to-Revenue : 1.56 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is OncoCyte COGS-to-Revenue?

OncoCyte's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.27 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.18 Mil.

OncoCyte's COGS to Revenue for the three months ended in Mar. 2024 was 1.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. OncoCyte's Gross Margin % for the three months ended in Mar. 2024 was -55.68%.

OncoCyte COGS-to-Revenue Historical Data

The historical data trend for OncoCyte's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoCyte COGS-to-Revenue Chart

OncoCyte Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

1.53

0.35

1.02

0.73

OncoCyte Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.97	0.41	0.42	1.37	1.56

OncoCyte COGS-to-Revenue Calculation

OncoCyte's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.09	/	1.503
	=	0.73

OncoCyte's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.274	/	0.176
	=	1.56

OncoCyte (LTS:0KCC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

OncoCyte's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.274 / 0.176
	=	-55.68 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

OncoCyte COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of OncoCyte's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoCyte (LTS:0KCC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » OncoCyte Corp (LTS:0KCC) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

OCX:USA

Address

15 Cushing, Irvine, CA, USA, 92618

Website

https://www.oncocyte.com

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States.

OncoCyte (LTS:0KCC) Headlines

No Headlines